PRODUCT DETAILS

About Tresiba 100 Units/ml Penfill

INSULIN DEGLUDEC belongs to a group of medication called 'anti-diabetic' primarily used for the treatment of type 1 and type 2 diabetes mellitus in both children (above 1 year of age) and adults. Diabetes is a disease where your body does not produce enough insulin to control the level of your blood sugar. Treatment with INSULIN DEGLUDEC helps to prevent complications from your diabetes.

INSULIN DEGLUDEC contains insulin degludec which is a fast-acting insulin that works rapidly to normalize blood sugar levels by helping the sugar move from the blood into other tissues of the body. It typically begins working after 60 minutes and is a long-acting insulin preparation (lasts for more than 24 hours). It prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses the production of sugar in the liver.

Uses of Tresiba 100 Units/ml Penfill

Type 1 diabetes mellitus, Type 2 diabetes mellitus

Medicinal Benefits of Tresiba 100 Units/ml Penfill

INSULIN DEGLUDEC works by ensuring rapid and consistent sugar control. INSULIN DEGLUDEC is a long-acting synthetic form of insulin that helps lower blood sugar levels by replacing the insulin that is produced by the body naturally. This drug also helps in moving sugar from the blood into different parts of the body so that body can effectively use the sugar in producing energy. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses the production of sugar in the liver. INSULIN DEGLUDEC helps in improving the glycaemic control which in turn decreases the risk of progression of complications of diabetes like damage of retina (retinopathy), damage of kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer, and others. Besides this, INSULIN DEGLUDEC can be safely prescribed to the diabetic mother in the pregnancy as well as lactation stage

Directions for Use

INSULIN DEGLUDEC is injected under the skin, usually one time a day or as suggested by the doctor. If you are not well trained to self-administer INSULIN DEGLUDEC, ask a healthcare professional to administer it.INSULIN DEGLUDEC should not be given with insulin pump or mixed with other insulins. Procedure for self-injecting insulin: • You should wash your hand first before injecting insulin. • Then roll the insulin bottle and wipe the bottle top. • Now pull the plunger of the syringe down to an appropriate number of units your doctor has prescribed. • Push the needle into the bottle and push the syringe plunger down. • Now once again pull the plunger down to an appropriate number of units as prescribed by the doctor. • Pick the injection site and wipe it with an alcohol swab. Now, pinch up the skin and push the needle into the skin and then push the plunger in. • The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected. • After injecting the insulin pull out the needle and dispose of the syringe safely. And then you can have a meal or snack.

Side Effects of Tresiba 100 Units/ml Penfill

Like all medicines, INSULIN DEGLUDEC can cause side effects, although not everybody gets them. Common side effects of INSULIN DEGLUDEC include hypokalaemia (low potassium), hypoglycemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itchy skin). Severe hypoglycemia can lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death. It is not necessary for everyone to experience the above side effects. Please consult your doctor immediately if you experience worsening of any of the side-effects.

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

INSULIN DEGLUDEC is for subcutaneous (under the skin) use only. However, in rare cases, it can be given via infusion intravenously under medical supervision. If you are changing the insulin brand or if you need to inject your insulin by another method, it should be done under strict medical supervision. Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients at high risk of cardiac heart failure. The first hyperglycemia symptoms (high blood sugar level) may include excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite, and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain, and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. INSULIN DEGLUDEC may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma, and even death. Do not take INSULIN DEGLUDEC if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription recreational drugs.

Drug Interactions

Drug-Drug Interaction:

INSULIN DEGLUDEC may have an interaction with drugs that may increase the risk of antiarrhythmic (disopyramide), hemorheological agents (pentoxifylline), antidiabetic (pramlintide), bleeding disorder drugs (octreotide), antipsychotic (propoxyphene, phenothiazines), female sex hormones (progestogen, oestrogen), thyroid hormones (levothyroxine), anti-asthmatics (albuterol, epinephrine, terbutaline), an antidepressant (fluoxetine, lithium), lipid-lowering pills (reserpine, niacin, clonidine, fenofibrate, guanethidine), pain killers (aspirin), antibiotics (isoniazid), blood sugar enhancing pills (glucagon), male hormone testosterone analogue (danazol), antibiotic (pentamidine)

Drug-Disease Interaction:

 INSULIN DEGLUDEC should not be given to patients with kidney disease, liver disease, low blood sugar/glucose level (hypoglycaemia), and low potassium level (hypokalaemia).

Safety Advice

ALCOHOL

You are recommended not to consume alcohol along with INSULIN DEGLUDEC to avoid unpleasant side-effects. Alcohol may either decrease or increase the blood sugar level which can be fatal.

PREGNANCY

INSULIN DEGLUDEC can be used during pregnancy. Your insulin dose may need to be changed during pregnancy and after delivery.

BREAST FEEDING

INSULIN DEGLUDEC can be given safely to nursing mothers but only under the supervision of a physician.

DRIVING

Drive with caution, INSULIN DEGLUDEC usually causes drowsiness and affects driving ability. Your ability to concentrate and react may be reduced if you have hypoglycaemia (low blood sugar)

LIVER

INSULIN DEGLUDEC to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor

KIDNEY

INSULIN DEGLUDEC to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose may have to be adjusted by your doctor.